The Latest Breaking News from Path

UiPath's beat-and-raise quarter keeps the company on track to double earnings over the next few years as it dominates workflow automation.

Unity, Walgreens, and UiPath stocks are down but could rebound in January as tax loss selling fades. Learn why these stocks are worth watching.

The software industry is evolving rapidly due to AI integration, vertical-specific solutions, and rising demand for cost-efficient, scalable cloud services. So, let’s analyze UiPath (PATH) and C3.ai (AI) to determine which software stock offers more value. Read more.

Analysts see near-term concerns for UiPath after the company's Q3 results.

UiPath (NYSE:PATH) will release its quarterly earnings report on Thursday, 2024-12-05. Here's a brief overview for investors ahead of the announcement.

The robotics market is booming thanks to the robust enterprise and consumer demand fueled by technological advancements like AI and ML. Therefore, it could be suitable to invest in fundamentally strong robotics stocks Rockwell Automation (ROK), Teradyne (TER), and UiPath (PATH) for substantial benefit. Read on.

With trends like cloud computing and AI integration rising, mid-cap tech stocks offer strong potential upside with a unique blend of growth and adaptability. Thus, you might consider investing in midcap tech space, such as Open Text Corp (OTEX), Informatica (INFA), and UiPath (PATH), which have strong upside potential. Continue…

The post-election uncertainties surrounding President-elect Donald Trump’s proposals have fueled economic volatility. In these turbulent times, investing in stocks positioned for strong growth, such as UiPath (PATH), ExlService Holdings (EXLS), and Avanos Medical (AVNS), could be a smart move for investors seeking stability and long-term potential. Read on….

With robust demand, and the need for higher efficiency, the SAAS market is poised for continued growth and expansion. Therefore, it could be ideal to closely monitor high-growth SAAS stocks UiPath (PATH), CCC Intelligent Solutions (CCCS), and DocuSign (DOCU) for substantial benefit. Read on.

Across five blistering songs, Reading bruisers Sylosis summarise everything that makes them one of Britain’s best metal bands

UiPath’s (PATH) continued growth is fueled by solid demand for its innovative product offerings, strategic innovations, and optimistic analysts’ expectations. So, let’s analyze whether PATH is a buy today. Read more to find out.